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Abstract
Introduction: Cogan's Syndrome is typically characterised by a non syphilitic interstitial keratitis
(IK), with or without conjunctivitis, iritis or subconjunctival bleeding and progressive sensorineural
hearing loss within two years of ocular signs. Atypical ocular manifestations include episcleritis,
scleritis, posterior scleritis, retinal artery occlusion, choroiditis, retinal vasculitis, and optic disc
oedema. We report a case of Cogan's syndrome in with recurrent cystoid macular oedema was
the main feature.
Case presentation: A patient was diagnosed with Cogan's syndrome nearly 2 years after first
presentation. He had cystoid macular edema which failed to respond initially to steroid,
methotrexate and azothiaprine however resolved after treatment with mycophenolate mofetil.
Conclusion:  Cogan's syndrome is rare and presents a challenge in terms of diagnosis and
treatment. Recurrent cystoid macular oedema is a unique finding in this condition and can be
difficult to control. Multidisciplinary management of this multisystem disorder is vital.
Introduction
David Cogan first described typical Cogan's syndrome in
1945. It presents with non syphilitic interstitial keratitis
(IK), with or without conjunctivitis, iritis or subconjuncti-
val bleeding and Menier's like audiovestibular signs asso-
ciated with progressive sensorineural hearing loss within
two years of ocular signs [1] Atypical Cogan's encom-
passes other ocular or audiovestibular symptoms or a
delay of more than 2 years between them [2]. Atypical
ocular manifestations include episcleritis, scleritis, poste-
rior scleritis, retinal artery occlusion, choroiditis, retinal
vasculitis, and optic disc oedema with or without IK [3,4]
Cystoid macular edema (CMO) in Cogan's syndrome has
not been described before. Vollertsen et al in their review
report macular involvement, but do not describe the
pathology seen at the macula [5]. We report a case of
Cogan's syndrome in which recalcitrant CMO was the
main feature.
Case presentation
A 54 year old Caucasian man presented to eye casualty
with a history of blurred vision and grittiness in his right
eye (RE) for over six months. Snellen visual acuity was 6/
5 in both eyes. Examination revealed mild injection and a
stromal opacity with deep vascularisation in the superior
aspect of the right cornea. There was no associated inflam-
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mation in the anterior chamber and corneal sensation was
normal. Examination of the left eye was unremarkable. A
diagnosis of probable non necrotising herpetic stromal
keratitis was made and the eye treated with topical pred-
nisolone acetate 0.5%. Three weeks later, the patient was
asymptomatic and the injection had resolved. The topical
treatment was tapered and discontinued.
The patient, re-attended 3 months later with similar
symptoms along with acute onset tinnitus in the right ear
and deafness of 3 weeks duration. Ocular examination
revealed the corneal stromal opacity, which was now diag-
nosed as interstitial keratitis. There were no signs of active
inflammation in the eye. Blood tests were performed and
a high ESR (88 mm at 1 hour) was the only positive find-
ing. All autoantibodies including ANA, cANCA, pANCA
were negative, serum ACE was within normal limits, no
antibodies were found against treponema pallidum and
borrelia bergdorfi. The patient was referred to an otorhi-
nologist, who performed an audiogram, which revealed
bilateral sensorineural deafness.
Two years later the patient presented with blurred and dis-
torted vision in both eyes. Aided Snellen's acuity was 6/9
bilaterally. The right cornea still had the deep stromal
opacity with ghost vessels superiorly (fig 1). There was
mild anterior uveitis. There was mild anterior uveitis and
bilateral cystoid macular edema (CMO) (fig 2 and 3).
Topical steroids and ketorolac were commenced. Blood
tests revealed a raised ESR, serology for autoantibodies,
Treponema and Borrelia, serum ACE, chest X ray were nor-
mal.
A diagnosis of Cogan's syndrome was made after taking
into account the history, clinical findings and results of
investigations. The visual acuity over the next 2 weeks
deteriorated to 6/18 in the RE and 6/12 in the LE. Oral
Prednisolone (40 mg/day) was commenced as treatment.
The CMO resolved and hearing improved 2 weeks follow-
ing treatment. However, once Prednisolone was tapered
to 10 mg per day, the CMO recurred. Over a period of 1
year, the CMO fluctuated in severity inversely to the dose
of steroids. Triamcinolone acetonide (40 mg) was injected
into the orbital floor on two occasions with no benefit.
The patient developed secondary posterior subcapsular
cataract in the RE and steroid induced diabetes mellitus.
He was therefore commenced on intramuscular meth-
otrexate. The CMO did not respond to methotrexate, this
Right cornea showing stromal opacity with vascularisation in  the superior aspect Figure 1
Right cornea showing stromal opacity with vasculari-
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was therefore substituted with Azathioprine 125 mg daily.
The patient was intolerant to the azathioprine and was
commenced on Mycophenolate mofetil. CMO finally set-
tled with Mycophenolate mofetil which enabled tapering
off the oral steroid. There was no further deterioration of
vision and no recurrence of CMO over 6 months with
snellen visual acuity stabilising at 6/24 in the RE (6/12
with pinhole) and 6/9 in the LE.
Discussion
Cogan's syndrome is a rare auto immune disorder with
ocular, auditory and systemic manifestations. It appears
to occur in young adult Caucasians of either sex. The ocu-
lar involvement is variable, usually bilateral and can cause
moderate to severe visual loss. Vollertsen et al reported
blindness in 8 out of 156 eyes, with bilateral loss of vision
in 2 patients [5].
The disease course of Cogan's syndrome may vary with
some patients experiencing an initial flare lasting weeks or
months followed by slow progression, whilst others dis-
play recurrent ocular or vestibular flare ups. Permanent
deafness and death due to systemic manifestations may
also occur.
The aetiology and pathogenesis of Cogan's syndrome is
unclear. An autoimmune basis has been suggested with
description of autoantibodies against the inner ear and
endothelium [6]. Diagnosis however is based on clinical
findings and history.
Corticosteroids are the first line of treatment and it is
argued that if given early in the disease course can aid
recovery of the hearing. Immunosupressive drugs like
methotrexate, azathioprine, cyclosporine and cyclophos-
phamide have all been tried with varying degree of success
[7-10]. However in the absence of controlled trials, there
are no definitive therapeutic recommendations.
Conclusion
This case highlights the variability of presentation of this
rare syndrome and to our knowledge is the first described
case of Cogan's syndrome with recurring cystoid macular
oedema. Delay in diagnosis is common and can lead to
visual and auditory disability. It is a multisystem disease,
which can be sight threatening and aggressive therapeutic
intervention may be needed to control the ocular pathol-
ogy and prevent visual loss. Optimum management of
these patients needs close co-operation of the ophthal-
mologist, otorhinolaryngologist and physician.
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